BARDA and Cue Health will collaborate to accelerate the development, validation, and manufacturing of a portable, molecular diagnostic test capable of ...
Abbott today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the ...
First Rapid, Point-of-Care and Near-Patient Molecular Test for Detection of Virus that Causes COVID-19 Cepheid today announced it has received ...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) has given innovators some advanced warned it intends to release a ...
Following extensive support of, and collaboration with, public health professionals in China, Oxford Nanopore has shipped an additional 200 MinION ...
Researchers from the German Center for Infection Research (DZIF) at Charité – Universitätsmedizin Berlin have developed a new laboratory assay to detect the novel ...
A novel diagnostics technology that reads gene expression patterns in the immune system to distinguish bacterial infections from viral infections ...
The Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS) Office ...
Researchers from the Charles R. Drew University of Medicine and Science have filed a patent application for a new diagnostic ...
In a few short weeks, the Defense Threat Reduction Agency (DTRA) will host the 2019 Chemical and Biological Defense Science ...
Rapidly determining exposure to weaponized infectious agents, chemicals, or radiation is one of the greatest challenges of force protection and ...
Coating paper with a liquid-infused polymer and folding it into precise 3D geometries allows scientists to create cheap, portable laboratory ...
The equipment available for cellular and molecular biology in space is limited compared to capabilities found in laboratories on Earth. ...
A joint partnership between UMass Lowell and UMass Medical School in Worcester, M2D2 is a business incubator that helps medical-device ...
The U.S. Food and Drug Administration announced on 9 Nov that an emergency use authorization (EUA) has been issued for ...
DCN Dx, a developer and manufacturer of rapid point-of-care diagnostic tests, and E25Bio, an MIT-spinoff diagnostics company from the Gehrke ...
The Naval Research Laboratory (NRL) is seeking partners to advance technology developed for in vitro diagnostic devices that are amenable ...
The National Institute of Allergy and Infectious Diseases (NIAID) is developing a strategic framework to advance tuberculosis (TB) research and ...
The Medical Countermeasure Systems - Joint Product Lead for Diagnostics (MCS-DX) is conducting research to inform future investments in diagnostics ...
General Atomics Electromagnetic Systems (GA-EMS) has been awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to develop ...
